Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.21 -0.02 (-0.91%)
As of: Sep 29, 2026 · 3:40 PM EDT

Xtl Biopharmaceuticals (XTLB) Total Current Liabilities (2009 - 2025)

Updated

Xtl Biopharmaceuticals (XTLB) recorded Total Current Liabilities of $420,000 in the quarter ended Dec 31, 2025, down 81.0% from $2.21 million a year earlier.

Analysis

Xtl Biopharmaceuticals (XTLB) Total Current Liabilities (2009 - 2025) Analysis & Trends

Starting with the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals' Total Current Liabilities history includes 49 quarters.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of 10.6% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Total Current Liabilities came in at $2.21 million in the year ended Dec 31, 2024 (+971.4%), $206,000 in the year ended Dec 31, 2023 (+10.2%), $187,000 in the year ended Dec 31, 2022 (-85.4%) and $1.29 million in the year ended Dec 31, 2021 (+405.9%).
  • The figure for the quarter ended Dec 31, 2025 is the lowest quarterly Total Current Liabilities since the quarter ended Jun 30, 2024.
  • On a year-over-year basis, Total Current Liabilities rose in two of the last four quarters, with growth averaging 221.0%.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 971.4% in the quarter ended Dec 31, 2024, against a decline of 85.4% in the quarter ended Dec 31, 2022 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Xtl Biopharmaceuticals 2.11 Bn 2.11 Bn - 420,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 420,000.00
Dec 31, 2024 2.21 Mn
Jun 30, 2024 165,000.00
Mar 31, 2024 223,000.00
Dec 31, 2023 206,000.00
Sep 30, 2023 162,000.00
Jun 30, 2023 163,000.00
Mar 31, 2023 241,000.00
Dec 31, 2022 187,000.00
Sep 30, 2022 153,000.00
Jun 30, 2022 194,000.00
Mar 31, 2022 260,000.00
Dec 31, 2021 1.29 Mn
Sep 30, 2021 185,000.00
Mar 31, 2021 251,000.00
Dec 31, 2020 254,000.00
Sep 30, 2020 182,000.00
Jun 30, 2020 194,000.00
Mar 31, 2020 244,000.00
Dec 31, 2019 232,000.00
API Access

Xtl Biopharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=XTLB&period=max&api_key=YOUR_API_KEY